We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
-4.36%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$44.1B
AUM Growth
+$629M
(+1.4%)
Cap. Flow
+$2.39B
Cap. Flow
% of AUM
5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.51%
Holding
3,945
New
199
Increased
895
Reduced
1,260
Closed
190
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$500M |
| 2 |
Archer Daniels Midland
ADM
|
+$463M |
| 3 |
Hewlett Packard
HPE
|
+$425M |
| 4 |
Gen Digital
GEN
|
+$379M |
| 5 |
WCC
WESCO International
WCC
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$598M |
| 2 |
ExxonMobil
XOM
|
+$504M |
| 3 |
Chevron
CVX
|
+$443M |
| 4 |
Occidental Petroleum
OXY
|
+$439M |
| 5 |
Cummins
CMI
|
+$414M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.1% |
| 2 | Technology | 16.69% |
| 3 | Energy | 13.9% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Booz Allen Hamilton
BAH
$8.71B
| $27.1K | ﹤0.01% |
176
+19
| +12% | +$2.85K |
|
|
ACLX
1302
DELISTED
Arcellx
ACLX
| $26.9K | ﹤0.01% |
488
-105
| -18% | -$5.71K |
|
1303
Intellia Therapeutics
NTLA
$1.51B
| $26.5K | ﹤0.01% |
1,186
-241
| -17% | -$5.74K |
|
|
SWI
1304
DELISTED
SolarWinds Corporation Common Stock
SWI
| $26.1K | ﹤0.01% |
2,162
-502
| -19% | -$5.8K |
|
|
NNDM
1305
Nano Dimension
NNDM
$312M
| $26K | ﹤0.01% |
11,815
-1,936
| -14% | -$4.86K |
|
1306
JFrog
FROG
$9.87B
| $25.9K | ﹤0.01% |
690
-30
| -4% | -$1.1K |
|
|
FOLD
1307
DELISTED
Amicus Therapeutics
FOLD
| $25.8K | ﹤0.01% |
2,597
-871
| -25% | -$8.94K |
|
|
RNAM
1308
DELISTED
Avidity Biosciences
RNAM
| $25.4K | ﹤0.01% |
622
-309
| -33% | -$8.87K |
|
|
FARO
1309
DELISTED
Faro Technologies
FARO
| $25.2K | ﹤0.01% |
1,577
+468
| +42% | +$8.68K |
|
1310
Celldex Therapeutics
CLDX
$2.81B
| $25.2K | ﹤0.01% |
680
-210
| -24% | -$7.92K |
|
1311
Vera Therapeutics
VERA
$2.57B
| $25.1K | ﹤0.01% |
693
-117
| -14% | -$4.64K |
|
1312
AvePoint
AVPT
$2.71B
| $24.8K | ﹤0.01% |
+2,382
| New | +$20.7K |
|
1313
Semtech
SMTC
$11.1B
| $24.8K | ﹤0.01% |
829
-199
| -19% | -$6.96K |
|
1314
IDEAYA Biosciences
IDYA
$3.48B
| $24K | ﹤0.01% |
683
-252
| -27% | -$9.98K |
|
1315
Geron
GERN
$956M
| $23.3K | ﹤0.01% |
5,503
-5,720
| -51% | -$22.3K |
|
1316
Extreme Networks
EXTR
$3.88B
| $22.5K | ﹤0.01% |
1,672
-6,609,631
| -100% | -$75.9M |
|
1317
Beam Therapeutics
BEAM
$2.6B
| $22K | ﹤0.01% |
940
-194
| -17% | -$4.76K |
|
1318
MaxLinear
MXL
$5.7B
| $21.5K | ﹤0.01% |
1,069
-238
| -18% | -$4.68K |
|
1319
Immunovant
IMVT
$8.25B
| $21.1K | ﹤0.01% |
800
-543
| -40% | -$15.4K |
|
1320
Syndax Pharmaceuticals
SNDX
$1.86B
| $20.8K | ﹤0.01% |
1,012
-722
| -42% | -$15.1K |
|
1321
Denali Therapeutics
DNLI
$3.78B
| $20K | ﹤0.01% |
862
-1,163
| -57% | -$22.3K |
|
|
ECC
1322
Eagle Point Credit Company
ECC
$476M
| – | – |
0
| – | – |
|
1323
Novavax
NVAX
$1.26B
| $18.9K | ﹤0.01% |
1,489
-6,339
| -81% | -$63.8K |
|
1324
Agios Pharmaceuticals
AGIO
$2.25B
| $18.8K | ﹤0.01% |
437
-594
| -58% | -$21.4K |
|
1325
Janux Therapeutics
JANX
$957M
| $18.4K | ﹤0.01% |
+439
| New | +$20.6K |
|
Similar funds
SAM
Pacer Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Pacer Advisors held 3,945 positions worth $44.1B, up 1.4% from $43.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Pacer Advisors deployed $2.39B of net new capital in Q2 2024, opening 199 new positions and adding to 895 existing holdings. Its largest new stake was Academy Sports + Outdoors: 3,268,629 shares worth $174M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 17% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Vistra, an estimated $598M trimmed.
- Pacer Advisors's largest Q2 2024 buy was Academy Sports + Outdoors: 3,268,629 shares worth $174M.
- Pacer Advisors added most to Halliburton in Q2 2024, an estimated $500M increase.
- Pacer Advisors's biggest Q2 2024 reduction was Vistra, cutting an estimated $598M.
- Pacer Advisors fully exited American Eagle Outfitters in Q2 2024, selling an estimated $218M.
- Pacer Advisors's ten largest holdings make up 12% of its $44.1B portfolio in Q2 2024.
- Pacer Advisors opened 199 new positions and closed 190 in Q2 2024.
- Pacer Advisors's portfolio value rose 1.4% quarter-over-quarter to $44.1B.
Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.